MedTrace Logo

Early Detection of Ventilator-associated Pneumonia (VAP)

NCT02753608 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2018-07-20

No results posted yet for this study

Summary

The study goal consists in the sequential collection of exhaled breath condensates (EBC) from patients receiving invasive ventilation. Subsequent Raman spectroscopy aims at the identification of putative biomarkers that could enable rapid early distinction of Ventilator-associated pneumonia.

Conditions

  • Pneumonia, Ventilator-associated

Interventions

OTHER

Collection of exhaled breath condensate

An sampling device (authorized for this use) will be connected to the expiratory line of the ventilator. Exhaled breath condensates accumulate in a cooled container.

Sponsors & Collaborators

  • Jena University Hospital

    lead OTHER

Principal Investigators

  • Mathias Pletz, MD · Jena University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-28
Primary Completion
2017-12-31
Completion
2018-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02753608 on ClinicalTrials.gov